CELLg8™ Technology Uses Naturally Occurring Lipids to Increase Bioavailability of Active Nutrients in Supplements

VANCOUVER, WA / ACCESSWIRE / November 10, 2020 / ORCHID VENTURES, INC. (CSE:ORCD)(OTC PINK:ORVRF) (the “Company” or “Orchid”), a multi-state cannabis innovation company, is pleased to announce that multi-state brand, Stash Fine Edibles and Concentrates, has launched CELLg8® gummies in retail outlets throughout Oregon. These are the first THC CELLg8® products available in the US and feature clinically proven CELLg8®

Nature has given us a unique tool to thwart the destructive acids in our stomach: lipids. Liposomes are lipids injected with vitamins, minerals or other active compounds. Colorado-based private label supplement manufacturer, Valimenta Labs proudly introduces its proprietary, patent pending CELLg8™ technology to the supplement industry that will be released in CELLg8™ liquid February. Headquartered out of its state-of-the-art cGMP Certified lab

FORT COLLINS, Colo. — Post-traumatic stress disorder (PTSD) affects nearly 2.5 million veterans in the U.S. Its symptoms can be massive barriers for vets returning to civilian life. One company is trying to use the benefits of CBD to combat PTSD.

IRVINE, CA / ACCESSWIRE / April 2, 2020 / ORCHID VENTURES, INC. (CSE:ORCD)(OTCPINK:ORVRF) (the “Company” or “Orchid”), a multi-state cannabis company, is pleased to announce that Orchid, through a wholly owned subsidiary, has entered into a licensing agreement, dated March 31, 2020 (the “Licensing Agreement”) with two privately held nutrient delivery system companies. The Licensing Agreement provides the Company with